Regulatory Sciences and Due Diligence SCHEDULE A CALL Regulatory Sciences Guidance on nonclinical and clinical regulatory strategy on all biopharmaceutical products Expert advice on orphan drugs designation, break-through therapy, accelerated approval, ANDA and 505(b)(2) submissions Conduct scientific and business centric due diligence assessments (on-site and/or electronic) of new drugs and acquisition Services Drug HuntingADC Drug DevelopmentImmuno-OncologyDiscoveryPreclinical DevelopmentClinical DevelopmentCMCTranslational SciencesRegulatory Sciences SCHEDULE A CALL
